Endocannabinoid system dysfunction in mood and related disorders:
https://www.ncbi.nlm.nih.gov/pubmed/21916860
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives:
https://www.ncbi.nlm.nih.gov/pubmed/21693551
Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa:
https://www.ncbi.nlm.nih.gov/pubmed/24923339
The endocannabinoid system and the treatment of mood and anxiety disorders:
https://www.ncbi.nlm.nih.gov/pubmed/19839936
Endocannabinoid signaling in the etiology and treatment of major depressive illness:
https://www.ncbi.nlm.nih.gov/pubmed/24180398
Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L:
https://www.ncbi.nlm.nih.gov/pubmed/20332000
The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants:
https://www.ncbi.nlm.nih.gov/pubmed/19732971
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors:
https://www.ncbi.nlm.nih.gov/pubmed/26711860
Pregabalin associated discontinuation symptoms (A case study):
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284877/
Side effects of common psychiatric drugs:
https://www.cchrint.org/pdfs/The_Side_Effects_of_Common_Psychiatric_Drugs.pdf
